37,054 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Acquired by Capital Fund Management S.A.

Capital Fund Management S.A. bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 37,054 shares of the medical device company's stock, valued at approximately $3,406,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Norges Bank purchased a new stake in shares of Cooper Companies during the 4th quarter valued at $217,906,000. FMR LLC grew its position in Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock valued at $203,911,000 after acquiring an additional 1,095,805 shares during the period. Raymond James Financial Inc. acquired a new stake in Cooper Companies during the fourth quarter worth about $64,826,000. Victory Capital Management Inc. raised its holdings in shares of Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after purchasing an additional 574,899 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after purchasing an additional 573,908 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of COO stock traded up $1.28 on Friday, hitting $79.51. 2,096,454 shares of the stock traded hands, compared to its average volume of 1,409,059. The company has a market capitalization of $15.90 billion, a PE ratio of 40.77, a PEG ratio of 2.25 and a beta of 1.01. The company's fifty day moving average is $83.06 and its 200 day moving average is $93.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the topic of several research reports. Robert W. Baird cut their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a report on Friday, March 7th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Citigroup decreased their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Stifel Nicolaus cut their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, BNP Paribas upgraded Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.